Streetbeat News

Stock Prices

AVNS

Avanos Medical has provided its FY23 revenue guidance, expecting it to be between $675M-$685M, which is in line with the $680.63M estimate. The company also expects its FY23 adjusted EPS to be between $1.05-$1.15, which is also in line with the $1.09 estimate. The outlook remains unchanged from the prior forecast.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:21 am

EXFY

GLGI

RCG

Insiders have recently bought shares in Expensify, Inc (EXFY), Greystone Logistics, Inc. (GLGI), and RENN Fund, Inc. (RCG). SF Roofdeck GP, a 10% owner of EXFY, acquired 168,894 shares at an average price of $2.48. Drew T Lockard, a director at GLGI, acquired 12,000 shares at an average price of $1.03. RCG's President and CEO, Murray Stahl, acquired 413 shares at an average price of $1.73.

Portfolio Pulse from Lisa Levin

November 01, 2023 | 11:19 am

DTE

DTE Energy has revised its FY23 operating EPS guidance from $6.09-$6.40 to $5.65-$5.85, lower than the $6.2 consensus. The revision is due to additional headwinds from storms and cooler weather experienced in Q3. The company plans to offset the majority of these headwinds in 2023.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:18 am

IQV

IQVIA has forecasted its Q4 FY23 revenue to be between $3.769B and $3.804B, which is lower than the consensus estimate of $3.96B.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:15 am

IQV

IQVIA has forecasted its Q4 FY23 adjusted EPS to be between $2.79 and $2.86, which is lower than the consensus estimate of $2.94.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:14 am

SUN

Sunoco has updated its financial forecast for FY23, now expecting its adjusted EBITDA to be above $935 million.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:12 am

SLN

Silence Therapeutics has reported topline results from its Phase 1 multiple dose study of Zerlasiran. The study found that Lp(a) levels remained around 90% lower than baseline at the study endpoint.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:12 am

PERI

Perion Network has projected its FY23 revenue to be between $730M and $750M, which is in line with the estimated $741.29M.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:11 am

CCRD

CoreCard (NYSE:CCRD) reported Q3 GAAP EPS of $(0.03), a decrease of 118.75% from $0.16 per share last year. Quarterly sales were $13.40 million, missing the analyst consensus estimate of $14.30 million by 6.30% and marking a 7.27% decrease from $14.45 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:09 am

DFIN

Donnelley Financial Solns (NYSE:DFIN) reported Q3 earnings of $0.72 per share, beating the analyst consensus estimate of $0.60 by 20%. However, the company's quarterly sales of $180.00 million missed the analyst consensus estimate of $186.62 million by 3.55%. This represents a 6.49% decrease in earnings and a 4.61% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:07 am